What did @bajandriver973 actually say?
Roughly 28 to 32 hours after injecting tirzepatide 7.5mg, this creator described being so exhausted that cooking dinner "had me so exhausted" and eating almost nothing, just a spoonful of mashed potatoes and three wings. They're connecting the fatigue directly to the dose increase, calling it their worst dose yet for energy and predicting "serious" appetite suppression going forward.
To be clear about what they're actually claiming: dose-dependent fatigue, dramatic appetite loss in the first days post-injection, and a sense that 7.5mg hits differently than lower doses. Those are distinct claims and they deserve to be evaluated separately, because some hold up better than others.
Does the science back this up?
Fatigue after a tirzepatide dose increase is real and documented. Yes, the science backs the core observation, though the mechanism is more complicated than most TikTok content suggests.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) tracked adverse events across the tirzepatide dose escalation schedule, and fatigue was reported in roughly 9 to 13 percent of participants, with rates tending to cluster around dose escalation windows. More relevant here, a 2023 pharmacodynamic analysis published in Diabetes Care (Rosenstock et al.) found that GIP and GLP-1 dual agonism produces stronger central nervous system effects than GLP-1 alone, including effects on energy regulation in the hypothalamus. That's not just nausea making you tired. There appears to be a direct CNS component. Separately, acute caloric restriction, which is exactly what this creator is experiencing, is itself a driver of fatigue. When you eat one spoonful of mashed potatoes and three wings in a day, your body notices.
What did they get wrong (or right)?
They got the fatigue observation right. Where they overstep is the word "suppression," which implies a sustained, serious clinical effect rather than a transient dose-escalation response.
The available data suggests most patients see fatigue peak in the first one to three days post-injection and then ease as the week progresses. Reporting from the SURMOUNT program consistently showed that GI and energy-related side effects were most pronounced during the escalation phase, not at maintenance doses. If this creator is still exhausted by day seven or eight, that's worth a call to their prescriber. But predicting "serious suppression" as a baseline expectation for 7.5mg overstates the evidence. It also risks discouraging other patients who might tolerate this dose fine. To give credit: the observation that appetite vanished faster than energy did is actually consistent with how tirzepatide works. Appetite suppression via GLP-1 and GIP receptor activity can precede the body's adaptation to lower caloric intake, which is probably why fatigue hits harder than expected early on.
What should you actually know?
If you're escalating to 7.5mg and you feel wrecked for the first two or three days, that is not unusual. It is also not a reason to panic or assume the drug is failing you.
There are a few practical things worth knowing. First, the fatigue loop here is partly self-reinforcing: the drug suppresses appetite, you eat almost nothing, low caloric intake worsens fatigue, and then you attribute all of it to the medication. Both things are true at once. Second, tirzepatide's half-life is approximately five days (Eli Lilly prescribing information, 2023), meaning peak plasma levels occur a day or two post-injection, which lines up with when this creator felt worst. Third, individual variability in response is significant. Not everyone hits a wall at 7.5mg. Some patients report the opposite, actually feeling more energy once nausea from lower doses resolves. This video captures one person's experience on one day. Treat it accordingly, not as a forecast for your own treatment.
- Eat something, even small amounts, to avoid compounding medication fatigue with caloric-deficit fatigue.
- Track fatigue day by day across your injection week, not just in the first 48 hours.
- If fatigue is severe or lasts beyond day four or five post-injection, contact your prescriber. It may warrant a dose adjustment or timeline change.